LUKAS SCHEIBLER - 10 Jun 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF INNOVATION OFFICER
Signature
/s/ David Watson, attorney-in-fact for Lukas Scheibler
Issuer symbol
APLS
Transactions as of
10 Jun 2021
Net transactions value
-$205,020
Form type
4
Filing time
11 Jun 2021, 16:07:21 UTC
Next filing
24 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $205,020 -3,417 -11% $60.00 26,651 10 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 778 shares from 04/30/21 ESPP Purchase.
F2 This is a scheduled sale from 10B5-1 trading plan.